We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Targeting immunogenic cell stress and death for cancer therapy

    Immunogenic cell death (ICD), which results from insufficient cellular adaptation to specific stressors, occupies a central position in the...

    Lorenzo Galluzzi, Emma Guilbaud, ... Francesco M. Marincola in Nature Reviews Drug Discovery
    Article 15 April 2024
  2. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity

    Most metastatic cancers remain incurable due to the emergence of apoptosis-resistant clones, fuelled by intratumour heterogeneity and tumour...

    Pascal Meier, Arnaud J. Legrand, ... John Silke in Nature Reviews Cancer
    Article 07 March 2024
  3. In situ chemoimmunotherapy hydrogel elicits immunogenic cell death and evokes efficient antitumor immune response

    Background

    Chemoimmunotherapy has shown promising advantages of eliciting immunogenic cell death and activating anti-tumor immune responses. However,...

    Qin Liu, Rui Xu, ... Baorui Liu in Journal of Translational Medicine
    Article Open access 09 April 2024
  4. Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation

    Background

    Despite advancements in chronic myeloid leukemia (CML) therapy with tyrosine kinase inhibitors (TKIs), resistance and intolerance remain...

    Barbora Orlikova-Boyer, Anne Lorant, ... Marc Diederich in Biomarker Research
    Article Open access 04 May 2024
  5. Immunogenic cell death in cancer: concept and therapeutic implications

    Mammalian cells responding to specific perturbations of homeostasis can undergo a regulated variant of cell death that elicits adaptive immune...

    Lorenzo Galluzzi, Oliver Kepp, ... Francesco M. Marincola in Journal of Translational Medicine
    Article Open access 02 March 2023
  6. Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds

    A growing body of evidence indicates that the anticancer effect of the immune system can be activated by the immunogenic modulation of dying cancer...

    Mina Amiri, Ommoleila Molavi, ... Soheila Montazersaheb in Cancer Cell International
    Article Open access 13 September 2023
  7. Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers

    Although irradiated induced-pluripotent stem cells (iPSCs) as a prophylactic cancer vaccine elicit an antitumor immune response, the therapeutic...

    Kevin Chih-Yang Huang, William Tzu-Liang Chen, ... Tao-Wei Ke in npj Vaccines
    Article Open access 31 May 2024
  8. Immunogenic hypofractionated radiotherapy sensitising head and neck squamous cell carcinoma to anti-PD-L1 therapy in MDSC-dependent manner

    Background

    Enhancing the response rate of immunotherapy will aid in the success of cancer treatment. Here, we aimed to explore the combined effect of...

    Liang Mao, Jun-Jie Zhou, ... Zhi-Jun Sun in British Journal of Cancer
    Article 28 March 2023
  9. Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry

    Cancer plasticity is now a recognized new hallmark of cancer which is due to disturbances of cell differentiation programs. It is manifested not only...

    József Tímár, Kenneth V. Honn, ... Sirpa Jalkanen in Cancer and Metastasis Reviews
    Article Open access 08 February 2023
  10. Immunogenic cell stress and death

    Dying mammalian cells emit numerous signals that interact with the host to dictate the immunological correlates of cellular stress and death. In the...

    Guido Kroemer, Claudia Galassi, ... Lorenzo Galluzzi in Nature Immunology
    Article 10 February 2022
  11. Hyperthermia inhibits cellular function and induces immunogenic cell death in renal cell carcinoma

    Background

    In recent years, hyperthermia has been widely applied as a novel strategy for cancer treatment due to its multiple antitumour effects. In...

    Yin Huaqi, Dong Bingqi, ... Yang Tiejun in BMC Cancer
    Article Open access 12 October 2023
  12. Investigating the Immunogenic Cell Death-Dependent Subtypes and Prognostic Signature of Triple-Negative Breast Cancer

    Recently, immunotherapy has emerged as a promising and effective method for treating triple-negative breast cancer (TNBC). However, challenges still...

    Youyang Shi, Yuanyuan Wu, ... Sheng Liu in Phenomics
    Article 01 February 2024
  13. Immunological characteristics of immunogenic cell death genes and malignant progression driving roles of TLR4 in anaplastic thyroid carcinoma

    Anaplastic thyroid carcinoma (ATC) was a rare malignancy featured with the weak immunotherapeutic response. So far, disorders of immunogenic cell...

    Tong Xu, Chaozhuang Zhu, ... ** Huang in BMC Cancer
    Article Open access 21 November 2023
  14. mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents

    Despite the availability of live-attenuated oral vaccines, rotavirus remains a major cause of severe childhood diarrhea worldwide. Due to the growing...

    Sandro Roier, Vidya Mangala Prasad, ... Susanne Rauch in npj Vaccines
    Article Open access 22 December 2023
  15. Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys

    HIV affects more than 38 million people worldwide. Although HIV can be effectively treated by lifelong combination antiretroviral therapy, only a...

    Archana V. Boopathy, Bhawna Sharma, ... Sarah Schmidt in npj Vaccines
    Article Open access 10 November 2023
  16. Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment

    Background

    This study aimed to explore the clinical significance of immunogenic cell death (ICD) in acute myeloid leukemia (AML) and its relationship...

    Yongyu Chen, Xue Qiu, Rongrong Liu in BMC Medical Genomics
    Article Open access 26 April 2024
  17. A High Threshold of Biotherapeutic Aggregate Numbers is Needed to Induce an Immunogenic Response In Vitro, In Vivo, and in the Clinic

    Background and Purpose

    There is concern that subvisible aggregates in biotherapeutic drug products pose a risk to patient safety. We investigated the...

    Joseph R. Cohen, Stephen R. Brych, ... Marisa K. Joubert in Pharmaceutical Research
    Article 22 March 2024
  18. The Influence of the Synthetic Organoselenium Preparation 974zh on the Immunogenic Activity of Yersinia pestis EV Vaccine Strain NIIEG

    In the present study, a stimulating effect of a new synthetic organoselenium compound 2,6-dipyridinium-9-selenabicyclo[3.3.1]nonandibromide (974zh)...

    V. I. Dubrovina, O. V. Yur’eva, ... S. V. Balakhonov in Bulletin of Experimental Biology and Medicine
    Article 01 August 2023
  19. Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light

    Vaccination against COVID-19 is the most effective method of controlling the spread of SARS-CoV-2 and reducing mortality from this disease. The...

    A. V. Gracheva, E. R. Korchevaya, ... Evgeny B. Faizuloev in Archives of Virology
    Article 20 July 2022
Did you find what you were looking for? Share feedback.